WIN378 Shows Six-Month Pharmacology as Phase III Begins
Windward Bio reported interim results from the randomized, double-blind Phase II portion of POLARIS-1 in uncontrolled moderate-to-severe asthma and initiated the seamless Phase III portion. Among the first 98 of 147 Phase II participants,…
